Diagnostic and Prognostic Values of miRNAs in High-Grade Gliomas: A Systematic Review
Open Access
- 15 January 2025
- journal article
- review article
- Published by F1000 Research Ltd in F1000Research
- Vol. 13, 796
Abstract
Background Gliomas, particularly glioblastomas, have grim prognoses, necessitating early diagnostic and prognostic indicators. MicroRNAs (miRNAs), influential in cancer research, show potential as glioma biomarkers. This systematic review aimed to examine the efficacy of miRNAs in the diagnosis and prognosis of high-grade glioma. Methods A comprehensive search was conducted of PubMed, EMBASE, Cochrane Library, and Web of Science for studies published from 2013 to 2023. The eligibility criteria included high-grade glioma, histopathological confirmation, miRNA samples from cerebrospinal fluid or plasma, and relevant outcome data. Studies were excluded if they were experimental or reviews and not in English. Results Of the 1120 initial results, 8 studies involving 660 subjects met the inclusion criteria. Several studies have assessed miRNA expression and its association with diagnosis and prognosis of high-grade gliomas. Overexpression of miR-221, miR-222, miR-210, miR-21, miR-125b, and miR-223 and under-expression of miR-15b and miR-124-3p showed significant potential in differentiating high-grade glioma patients from controls. Additionally, miRNAs are associated with distinct tumorigenic pathways. Conclusion Elevated or depressed expression levels of specific circulating miRNAs hold significant promise as noninvasive biomarkers for the diagnosis and prognosis of high-grade glioma. These miRNAs offer valuable insights into disease progression and patient outcome. Further validation through extensive clinical trials and in-depth mechanistic studies is essential to realize their full clinical utility.Keywords
This publication has 16 references indexed in Scilit:
- Circulating Biomarkers for Glioma: A ReviewNeurosurgery, 2021
- The Prognostic Significance of miR‐21 Expression among Surgically Resected Hepatocellular Carcinoma Patients: Evidence from a Meta‐Analysis and Retrospective Cohort StudyBioMed Research International, 2020
- Prognostic Significance of MicroRNAs in Glioma: A Systematic Review and Meta-AnalysisBioMed Research International, 2019
- MicroRNA as Biomarkers and DiagnosticsJournal of Cellular Physiology, 2015
- Decreased Expression of miR-15b in Human Gliomas Is Associated with Poor PrognosisCancer Biotherapy and Radiopharmaceuticals, 2015
- Plasma miR-221/222 Family as Novel Descriptive and Prognostic Biomarkers for GliomaMolecular Neurobiology, 2015
- Predictive and Prognostic Roles of Abnormal Expression of Tissue miR-125b, miR-221, and miR-222 in GliomaMolecular Neurobiology, 2014
- A MiRNA Signature for Defining Aggressive Phenotype and Prognosis in GliomasPLOS ONE, 2014
- MicroRNA-210 overexpression predicts poorer prognosis in glioma patientsJournal of Clinical Neuroscience, 2014
- MicroRNA-21 expression is associated with overall survival in patients with gliomaDiagnostic Pathology, 2013